🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Richard D. Carvajal

Northwell Health

ORCID: 0000-0002-3796-1118

Also affiliated with Cold Spring Harbor Laboratory, Columbia University Irving Medical Center, Cancer Research Center, North Shore Diabetes and Endocrine Associates

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9
Top 16%
1.3DataRank
Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

Papers

Driven by 20 papers — median percentile 82. Top paper: “Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification”.

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of Clinical Oncology(2022)10.1200/jco.22.00830
N/A
2.2DataRank · unranked
97 citations

Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony Elias, Richard D. Carvajal +15 more

Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens

Nature Genetics(2023)10.1038/s41588-022-01268-9
Top 16%
1.3DataRank
Top 16%59 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Irving Barrera +20 more

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020
Top 20%
1.0DataRank
Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

Cell(2022)10.1016/j.cell.2022.06.007
N/A
0.807DataRank · unranked
216 citations

Johannes C. Melms, Amit Dipak Amin, Yiping Wang, Lindsay Caprio, Alcida Karz +54 more

MicroRNA‐based risk scoring system to identify early‐stage oral squamous cell carcinoma patients at high‐risk for cancer‐specific mortality

Head & Neck(2020)10.1002/hed.26089
N/A
0.628DataRank · unranked
65 citations

Shuang Wang, David I. Kutler, Richard D. Carvajal, Elizabeth Philipone, Tian Wang +8 more

MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell Carcinoma

Journal of Oncology(2021)10.1155/2021/8292453
N/A
0.241DataRank · unranked
4 citations

Regina M. Santella, Shuang Wang, David I. Kutler, Richard D. Carvajal, Elizabeth Philipone +14 more

1034TiP ARTISTRY-6: Nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous melanoma

Annals of Oncology(2021)10.1016/j.annonc.2021.08.1418
N/A
0DataRank · unranked
0 citations

Jeffrey S. Weber, Arkadiusz Z. Dudek, Jaspreet Singh Grewal, Inderjit Mehmi, Omid Hamid +7 more

SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005088
N/A
0DataRank · unranked
35 citations

Joshua Morin‐Baxter, Richard D. Carvajal, Maryum Cheema, Sunil Dubey, Hiroshi Nakagawa +7 more

A phase II study of biomarker-driven early discontinuation of anti–PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps9591
N/A
0DataRank · unranked
4 citations

Sandra J. Lee, Michael B. Atkins, Terence Z. Wong, Jennifer L. Guerriero, Thomas U. Marron +8 more

Multi-modal single-cell and whole-genome sequencing of minute, frozen specimens to propel clinical applications

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.13.480272
N/A
0DataRank · unranked
3 citations

Joy Linyue Fan, Johannes C. Melms, Amit Dipak Amin, Yohanna Georgis, Patricia Ho +15 more

592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0592
N/A
0DataRank · unranked
2 citations

Richard D. Carvajal, Diwakar Davar, Eduardo Castañón, Paolo A. Ascierto, Emiliano Calvo +16 more

Kinetics of RTK activation determine ERK reactivation and resistance to dual BRAF/MEK inhibition in melanoma

Cell Reports(2023)10.1016/j.celrep.2023.112570
N/A
0DataRank · unranked
35 citations

Richard D. Carvajal, Minah Kim, Hee Won Yang, Sung Soo Kim

Precision Dose-finding Cancer Clinical Trials in the Setting of Broadened Eligibility

arXiv (Cornell University)(2023)10.48550/arxiv.2301.04578
N/A
0DataRank · unranked
0 citations

Bin Cheng, Richard D. Carvajal, Shing M. Lee, Rebecca B. Silva

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000331
N/A
0DataRank · unranked
125 citations

Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate +23 more

Data from Angiopoietin-2–Dependent Spatial Vascular Destabilization Promotes T-cell Exclusion and Limits Immunotherapy in Melanoma

(2023)10.1158/0008-5472.c.6678572.v1
N/A
0DataRank · unranked
0 citations

Anahita Shiva, Portia Cummings, Seoyeon Kim, Sungsoo Kim, Eunhyeong Lee +10 more

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Cancer Research(2020)10.1158/0008-5472.can-19-2039
N/A
0DataRank · unranked
31 citations

Andrew Chen, Emanuelle M. Rizk, Douglas K. Marks, Margaret H. Bogardus, Thomas D. Hart +12 more

MicroRNA-based cancer mortality risk scoring system and hTERT expression linked with risk-adjusted treatment strategy in early-stage oral squamous cell carcinoma

medRxiv(2020)10.1101/2020.07.03.20145854
N/A
0DataRank · unranked
0 citations

Regina M. Santella, Shuang Wang, David I. Kutler, Richard D. Carvajal, Elizabeth Philipone +12 more

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001219
N/A
0DataRank · unranked
14 citations

Shaheer Khan, Matt Levin, Richard D. Carvajal, Angela J. Yoon, Tejus Satish

Multiregional genetic evolution of metastatic uveal melanoma

npj Genomic Medicine(2021)10.1038/s41525-021-00233-5
N/A
0DataRank · unranked
11 citations

Jessica Yang, Michael Durante, Alexander N. Shoushtari, Stergios J. Moschos, Kazimierz O. Wrzeszczyński +3 more

Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials

JCO Precision Oncology(2021)10.1200/po.21.00136
N/A
0DataRank · unranked
5 citations

Christina Yap, Richard D. Carvajal, Shing M. Lee, Rebecca B. Silva